4 Results for "

BTK-IN-8

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "BTK-IN-8" in MCE Product Catalog:

Cat. No.: HY-145884
CAS No.: 2824922-28-1
Target:  

Btk

Research Areas:  

Inflammation/Immunology

BTK-IN-8 is a potent and selective peripheral covalent BTK inhibitor (IC50=0.22 nM; Kd=0.91 nM). BTK-IN-8 has good whole blood CD69 cellular potency (IC50=0.029 µM) .
loading...
    loading...
Cat. No.: HY-128403
CAS No.: 2230724-66-8
Target:  

Btk

Research Areas:  

Inflammation/Immunology

BTK inhibitor 8 (Compound 27) is a Btk inhibitor with an IC50 of 0.11 nM. BTK inhibitor 8 inhibits Btk activity. BTK inhibitor 8 suppresses B cell activation. BTK inhibitor 8 is applicable to research related to arthritis and asthma .
loading...
    loading...
Cat. No.: HY-174850
CAS No.: 2941611-57-8
Target:  

Btk

Research Areas:  

Cancer

CFON-026 is a selective, orally active and non-covalent BTK inhibitor with an IC50 of 0.27  nM. CFON-026 has significant antitumor activity against wild-type BTK (TMD8 and REC-1) and all clinically relevant BTK resistance mutations (BTK C481S, T474I, L528W and V416L). CFON-026 induces complete tumor regression in TMD8 xenograft mice model. CFON-026 can be used for research of hematological cancers like chronic lymphocytic leukemia and waldenström macroglobulinemia .
loading...
    loading...
Cat. No.: HY-172822
Target:  

ByeTAC Btk

Research Areas:  

Cancer

TLT8 is a ByeTAC protein degrader targeting BTK. TLT8 non-covalently binds to Rpn-13 and BTK, thereby inducing BTK degradation. TLT8 can be used in chronic lymphocytic leukemia research. (Rpn-13 ligand: HY-159808; BTK ligand: HY-Z3101; linker: HY-172823) .
loading...
    loading...